TULA advocated again in the recent GIRFT documentation,
Promed has worked hard over the last 5 years with Mr Shamsuddin and Mr Agrawal to show TULA as a beneficial treatment to the NHS financially and most of all he benefit and improved experience for the patient. We continue to ensure TULA is accessible to all NHS hospitals in the UK.
TULA has now been linked to national pathway for treatment. So this is the start of the exponential increase in usage.